Transplantation and Cellular Therapy

Published by: Elsevier Inc.  

People

  1. Perales
    Perales
  2. Giralt
    Giralt
  3. Dahi
    Dahi
  4. Shah
    Shah
  5. Papanicolaou
    Papanicolaou
  6. Boelens
    Boelens
  7. Politikos
    Politikos
  8. Ponce
    Ponce
  9. Scordo
    Scordo
  10. Lin
    Lin

Groups

  1. Department of Medicine (148)
  2. Hematologic Malignancies, Division of (124)
  3. Center for Hematologic Malignancies (118)
  4. Bone Marrow Transplant (109)
  5. CTCR Scholars (54)
  6. Pediatrics, Department of (48)
  7. Survivorship Research (45)
  8. MSK Grad Students (42)
  9. Stem Cell Transplantation and Cellular Therapy Service (42)
  10. Master of Science in Clinical and Translational Cancer Research (41)
Search Within
Formats
  1. Journal Article (84)
  2. Meeting Abstract (53)
  3. Guidelines (29)
  4. Review (15)
  5. Editorial (13)
Groups
  1. Department of Medicine (148)
  2. Hematologic Malignancies, Division of (124)
  3. Center for Hematologic Malignancies (118)
  4. Bone Marrow Transplant (109)
  5. CTCR Scholars (54)
  6. Pediatrics, Department of (48)

More Groups

People
  1. Miguel-Angel Perales (66)
  2. Sergio Giralt (36)
  3. Parastoo Dahi (24)
  4. Sean Devlin (24)
  5. Gunjan Shah (23)
  6. Craig Sauter (20)

More People

Years
  1. 2025 (13)
  2. 2024 (28)
  3. 2023 (31)
  4. 2022 (82)
  5. 2021 (40)
Publishers
  1. Elsevier Inc. (194)

Results (194)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk Factors Associated with Sub-Optimal Outcomes and Hematotoxicity Following Obecabtagene Autoleucel (obe-cel) for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL)
    Meeting Abstract

    Sandhu, K. S.; Park, J. H.; Shaughnessy, P.; Logan, A. C.; Abedi, M.; Shah, B.; Bishop, M. R.; Deangelo, D. J.; Brugger, W.; Shang, J.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • CAR and ALL Hematotox Scores Predict Toxicity and Outcomes Among Recipients of Brexucabtagene Autoleucel for R/R ALL in the Real World Outcomes Collaborative of CAR-T in Adult ALL (ROCCA) Consortium
    Meeting Abstract

    Valtis, Y.; Lin, C. Y.; Nemirovsky, D.; Devlin, S.; Rejeski, K.; Shah, N. N.; Nair, M. S.; Jeyakumar, N.; Miller, K.; Zhang, A.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Enhancing the persistence and anti-tumor efficacy of CAR-T and CAR-NK cells through genetic disruption of death receptors
    Meeting Abstract

    Cohen, T. D.; Yi, F.; Zumbo, P.; Etilib, R.; Arkin, H.; Gormally, M.; Hackett, C. S.; Kropp, K.; Etxeberria, I.; Chandran, S. S.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • The Association of HLA-E ligand and NKG2 receptor variation with relapse and mortality after haploidentical related donor transplantation
    Journal Article

    Petersdorf, E. W.; McKallor, C.; Malkki, M.; Hsu, K.; He, M.; Spellman, S. R.; Gooley, T.; Stevenson, P.
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Tumor-infiltrating lymphocyte therapy for melanoma and other solid tumors: Looking back, yet moving forward
    Review

    Shoushtari, A. N.; Powell, D. J.
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Surgical considerations in tumor-infiltrating lymphocyte therapy: Challenges and opportunities
    Guidelines

    Kirane, A.; Lee, D.; Ariyan, C.
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • The clinical TIL experience in melanoma: Past, present, future
    Review

    Smithy, J. W.; Schoenfeld, A. J.; Betof Warner, A.
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • The adverse event landscape of stem cell transplant: Evidence for AGVHD driving early transplant associated toxicities
    Journal Article

    Takahashi, T.; Watkins, B.; Bratrude, B.; Neuberg, D.; Hebert, K.; Betz, K.; Yu, A.; Choi, S. W.; Davis, J.; Duncan, C.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Health-related values discussions with patients undergoing allogeneic and autologous stem cell transplant: Feasibility and acceptability of an early primary palliative care intervention
    Journal Article

    Cohen, A. G.; Cho, C.; Patterson, E.; Magaldi, J.; Doga, T.; Naputo, K.; Alvarez, K.; Giles, E.; Yang, G.; Hoque, A.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Letermovir for prevention of recurrent cytomegalovirus in high-risk allogeneic hematopoietic cell transplantation recipients
    Journal Article

    Han, G.; Stern, A.; Lee, Y. J.; Li, Y.; Dahi, P. B.; Tamari, R.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; Shaffer, B.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save

    • Transplantation and Cellular Therapy – authorized name for:

    Name ISSN / ISBN Publisher
    Transplantation and Cellular Therapy 26666367 Elsevier Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 Unknown
    Transplantation and Cellular Therapy 26666375 Unknown
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 American Society for Transplantation and Cellular Therapy
    Transplantation and Cellular Therapy 26666367 2020
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666375 The American Society for Transplantation and Cellular Therapy
    Transplantation and Cellular Therapy 26666367 2021
    Transplantation and Cellular Therapy 26666375 2024
    Transplantation and Cellular Therapy 26666375 Elsevier B.V.
    Transplantation and Cellular Therapy 2666-6375 Elsevier Science, Inc.
    Transplantation and Cellular Therapy 2666-6375 Elsevier Science, Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 2023
    Transplantation and Cellular Therapy 26666367 2022
    Transplantation and Cellular Therapy 26666367 The American Society for Transplantation and Cellular Therapy
    Transplantation and Cellular Therapy 26666367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 2024
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.